|
Re: Receptor Status
If it helps, triple negative BC seems to be especially vulnerable to Metformin, a common diabetes medication thought to effect breast cancer stem cells. There are numerous other cancer therapies in development that are not receptor specific. If you think about it from a big pharma standpoint, the cash cow is in therapies that work across the cancer spectrum. At least I hope that's the dynamic.
|